Our success stories
Read the stories from the teams behind some of our key achievements, including bringing drugs to market, licensing, forming startups and developing...
Our fund is managed by a team with a long-standing track record of sourcing, evaluating and completing spinout and partnering deals. Our independent investment committee is made up of investors, venture builders, and experts in science, knowledge transfer and industry, committed to helping turn cutting-edge innovations into cancer breakthroughs faster.